Files and links (1)
Accepted (AM)Open Access (License Unspecified), Open
Journal article
Electronic Nicotine Delivery Systems (ENDS) Use and Pregnancy II: Perinatal Outcomes Following ENDS Use During Pregnancy
Current addiction reports, v 8(3), pp 366-379
01 Sep 2021
PMID: 35368552
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Purpose of Review This review examines the risk of adverse perinatal outcomes following electronic nicotine delivery systems (ENDS) use during pregnancy, and considers whether there are sufficient data to support ENDS as a harm reduction approach during pregnancy. Recent Findings Seven papers assessed perinatal outcomes following ENDS use during pregnancy. There was evidence that ENDS use was associated with increased risk for some adverse perinatal outcomes (e.g., small for gestational age). However, the repeated use of data sets, insufficient data (e.g., timing of ENDS use, type of ENDS products used), and limited samples sizes contributed to mixed findings on the degree to which ENDS use (alone or in combination with combustible cigarettes (CC)) impacts the risk of adverse perinatal outcomes relative to CC smoking alone. The current data are still insufficient to support ENDS as a harm reduction approach, though findings do warrant concern and more detailed investigation of ENDS use during pregnancy. Future research directions, as well as implications for clinical recommendations and tobacco regulatory science, are discussed.
Metrics
Details
- Title
- Electronic Nicotine Delivery Systems (ENDS) Use and Pregnancy II: Perinatal Outcomes Following ENDS Use During Pregnancy
- Creators
- Elise E. DeVito - Yale UniversityTessa Fagle - Yale UniversityAlicia M. Allen - University of ArizonaRaina D. Pang - University of Southern CaliforniaNicole Petersen - Neurobehavioral SystemsPhilip H. Smith - Miami UniversityAndrea H. Weinberger - Yeshiva University
- Publication Details
- Current addiction reports, v 8(3), pp 366-379
- Publisher
- Springer Nature
- Number of pages
- 14
- Grant note
- Eunice Kennedy Shriver National Institute on Child Health and Development (NICHD) R01DA046360; R01HD100418; K01DA040043; R00DA045749 / National Institute on Drug Abuse (NIDA); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA) FDA Center for Tobacco Products (CTP); United States Department of Health & Human Services; US Food & Drug Administration (FDA)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- A.J. Drexel Autism Institute
- Web of Science ID
- WOS:000677558700001
- Scopus ID
- 2-s2.0-85110782989
- Other Identifier
- 991022031021504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Psychiatry
- Substance Abuse